Cvs health corporationCVS.US Overview
CVS Overall Performance
CVS AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
CVS Current Performance
1.29%
Cvs health corporation
0.13%
Avg of Sector
-0.69%
S&P500
CVS Key Information
CVS Financial Forecast
Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2025Q1 | ||||
| 2025Q2 | ||||
| 2025Q3 | ||||
| 2025Q4 | ||||
| 2026Q1 |
CVS Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
CVS Profile
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Price of CVS
CVS FAQ
When is CVS's latest earnings report released?
The most recent financial report for Cvs health corporation (CVS) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CVS's short-term business performance and financial health. For the latest updates on CVS's earnings releases, visit this page regularly.
Where does CVS fall in the P/E River chart?
According to historical valuation range analysis, Cvs health corporation (CVS)'s current price-to-earnings (P/E) ratio is 17.38, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of CVS?
According to the latest financial report, Cvs health corporation (CVS) reported an Operating Profit of 2.38B with an Operating Margin of 2.41% this period, representing a decline of 21.81% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is CVS's revenue growth?
In the latest financial report, Cvs health corporation (CVS) announced revenue of 98.92B, with a Year-Over-Year growth rate of 8.42%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does CVS have?
As of the end of the reporting period, Cvs health corporation (CVS) had total debt of 82.72B, with a debt ratio of 0.32. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does CVS have?
At the end of the period, Cvs health corporation (CVS) held Total Cash and Cash Equivalents of 11.79B, accounting for 0.05 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does CVS go with three margins increasing?
In the latest report, Cvs health corporation (CVS) achieved the “three margins increasing” benchmark, with a gross margin of 13.7%%, operating margin of 2.41%%, and net margin of 1%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CVS's profit trajectory and future growth potential.
Is CVS's EPS continuing to grow?
According to the past four quarterly reports, Cvs health corporation (CVS)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.81. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of CVS?
Cvs health corporation (CVS)'s Free Cash Flow (FCF) for the period is 1.29B, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 47.37% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of CVS?
The latest valuation data shows Cvs health corporation (CVS) has a Price-To-Earnings (PE) ratio of 17.38 and a Price/Earnings-To-Growth (PEG) ratio of -0.5. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.